BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7253550)

  • 1. Evaluation of a killed phase I Coxiella burnetii vaccine in cynomolgus monkeys (Macaca fascicularis).
    Kishimoto RA; Gonder JC; Johnson JW; Reynolds JA; Larson EW
    Lab Anim Sci; 1981 Feb; 31(1):48-51. PubMed ID: 7253550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cynomolgus (Macaca fascicularis) and rhesus (Macaca mulatta) monkeys as experimental models of acute Q fever after aerosol exposure to phase-I Coxiella burnetii.
    Waag DM; Byrne WR; Estep J; Gibbs P; Pitt ML; Banfield CM
    Lab Anim Sci; 1999 Dec; 49(6):634-8. PubMed ID: 10638499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experience in vaccinating farm animals for preventing Q fever in humans].
    Lisák V
    Tr Inst Im Pastera; 1989; 66():143-53, 174. PubMed ID: 2485300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Q fever (Coxiella burnetii) investigations in dairy cattle: persistence of antibodies after vaccination.
    Behymer DE; Biberstein EL; Riemann HP; Franti CE; Sawyer M
    Am J Vet Res; 1975 Jun; 36(6):781-84. PubMed ID: 1147331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vaccination with phase I and phase II Coxiella burnetii vaccines in pregnant goats.
    Arricau-Bouvery N; Souriau A; Bodier C; Dufour P; Rousset E; Rodolakis A
    Vaccine; 2005 Aug; 23(35):4392-402. PubMed ID: 16005747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of rickettsial antibody and cell-mediated reaction in cynomolgus monkeys (Macaca fascicularis).
    Kishimoto RA; Gonder JC
    Lab Anim Sci; 1980 Dec; 30(6):1016-7. PubMed ID: 7007722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol.
    Waag DM; England MJ; Tammariello RF; Byrne WR; Gibbs P; Banfield CM; Pitt ML
    Vaccine; 2002 Jun; 20(19-20):2623-34. PubMed ID: 12057622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenicity of chloroform-methanol-treated Coxiella burnetii preparations.
    Kazár J; Schramek S; Lisák V; Brezina R
    Acta Virol; 1987 Mar; 31(2):158-67. PubMed ID: 2886025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of Q fever phase I corpuscular vaccine to influence the persistence and reactivation of Coxiella burnetii infection in mouse and guinea pig tissues.
    Kazár J; Kovácová E
    Acta Virol; 1983 Sep; 27(5):418-28. PubMed ID: 6139946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Q fever (Coxiella burnetii) investigations in dairy cattle: challenge of immunity after vaccination.
    Behymer DE; Biberstein EL; Riemann HP; Franti CE; Sawyer M; Ruppanner R; Crenshaw GL
    Am J Vet Res; 1976 Jun; 37(6):631-4. PubMed ID: 937784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Q fever vaccination of sheep: challenge of immunity in ewes.
    Brooks DL; Ermel RW; Franti CE; Ruppanner R; Behymer DE; Williams JC; Stephenson EH
    Am J Vet Res; 1986 Jun; 47(6):1235-8. PubMed ID: 3729123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response in man following a small intradermal inoculation with Coxiella burnetii phase I vaccine.
    Peacock MG; Fiset P; Ormsbee RA; Wisseman CL
    Acta Virol; 1979 Jan; 23(1):73-81. PubMed ID: 35962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of dogs with Q fever vaccines: comparison of phase I, II and phase I CMR Coxiella burnetii vaccines.
    Williams JC; Peacock MG; Race RE
    Rev Elev Med Vet Pays Trop; 1993; 46(1-2):87-94. PubMed ID: 8134661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cynomolgus monkey model for experimental Q fever infection.
    Gonder JC; Kishimoto RA; Kastello MD; Pedersen CE; Larson EW
    J Infect Dis; 1979 Feb; 139(2):191-6. PubMed ID: 108342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization against Q-fever of naturally infected dairy cows.
    Sádecký E; Brezina R; Kazár J; Urvölgyi J
    Acta Virol; 1975 Nov; 19(6):486-8. PubMed ID: 1994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs.
    Marmion BP; Ormsbee RA; Kyrkou M; Wright J; Worswick DA; Izzo AA; Esterman A; Feery B; Shapiro RA
    Epidemiol Infect; 1990 Apr; 104(2):275-87. PubMed ID: 2323360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of vaccination by a phase I Coxiella burnetii-inactivated vaccine in goat herds in clinical Q fever situation.
    de Cremoux R; Rousset E; Touratier A; Audusseau G; Nicollet P; Ribaud D; David V; Le Pape M
    FEMS Immunol Med Microbiol; 2012 Feb; 64(1):104-6. PubMed ID: 22066485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination of cattle against Q-fever.
    Sádecký E; Brezina R; Michalovic M
    J Hyg Epidemiol Microbiol Immunol; 1975; 19(2):200-6. PubMed ID: 1236883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.